AU3632901A - Sustained release tablet formulations comprising clarithromycin - Google Patents

Sustained release tablet formulations comprising clarithromycin

Info

Publication number
AU3632901A
AU3632901A AU36329/01A AU3632901A AU3632901A AU 3632901 A AU3632901 A AU 3632901A AU 36329/01 A AU36329/01 A AU 36329/01A AU 3632901 A AU3632901 A AU 3632901A AU 3632901 A AU3632901 A AU 3632901A
Authority
AU
Australia
Prior art keywords
clarithromycin
sustained release
release tablet
tablet formulations
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36329/01A
Inventor
Levent Oner
Ahmet Toksoz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of AU3632901A publication Critical patent/AU3632901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU36329/01A 2000-01-05 2001-01-04 Sustained release tablet formulations comprising clarithromycin Abandoned AU3632901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TR2000/00054A TR200000054A2 (en) 2000-01-05 2000-01-05 Sustained-release tablet formulations containing clarithromycin.
TR2000/00054 2000-01-05
PCT/TR2001/000002 WO2001049246A2 (en) 2000-01-05 2001-01-04 Sustained release tablet formulations comprising clarithromycin

Publications (1)

Publication Number Publication Date
AU3632901A true AU3632901A (en) 2001-07-16

Family

ID=21622322

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36329/01A Abandoned AU3632901A (en) 2000-01-05 2001-01-04 Sustained release tablet formulations comprising clarithromycin

Country Status (3)

Country Link
AU (1) AU3632901A (en)
TR (1) TR200000054A2 (en)
WO (1) WO2001049246A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1285659B1 (en) * 2001-08-13 2007-06-27 Fondazione Salvatore Maugeri - Clinica del Lavoro e della Riabilitazione Use of clarithromycin compositions in the manufacture of a medicament for the treatment of arthritis deformans
CA2405918A1 (en) * 2001-10-01 2003-04-01 Ind-Swift Limited Controlled release macrolide pharmaceutical formulations
WO2005082331A2 (en) * 2004-02-26 2005-09-09 Ranbaxy Laboratories Limited Extended release tablets of clarithromycin
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0967256A (en) * 1995-08-31 1997-03-11 Taisho Pharmaceut Co Ltd Drug for common cold
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
SI20150A (en) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Directly compressible matrix for controlled release of the daily dose of clarytomicyne

Also Published As

Publication number Publication date
TR200000054A2 (en) 2001-08-21
WO2001049246A2 (en) 2001-07-12
WO2001049246A3 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
MXPA03003235A (en) Delayed release pharmaceutical formulations.
AU2002327068A1 (en) Immediate release tablet
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
AU2001279972A1 (en) Pesticidal formulations
EP1356809A4 (en) Sustained release preparations
AU2002229140A1 (en) Controlled release pharmaceutical composition
AUPR602501A0 (en) Sustained release pharmaceutical composition
AU2001264671A1 (en) Latency monitor
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
EP1151667A3 (en) Plant-activating agent
AU2001264264A1 (en) Sustained release compositions
AU2001248772A1 (en) Sustained release drug compositions
AU2001246861A1 (en) Sustained release preparations
AU2002221099A1 (en) Combination drugs
PL366067A1 (en) Oxayolidinone tablet formulation
AU2001232244A1 (en) Drug comprising combination
AU2002219249A1 (en) Enteric-coated drug formulations and their manufacture
AU2001295855A1 (en) Chocolate spread
AU2001269408A1 (en) Miniature thermal device
AU2002213399A1 (en) Detergent tablet
AU3632901A (en) Sustained release tablet formulations comprising clarithromycin
AU2001241187A1 (en) Sustained release oral preparations
AU2001295303A1 (en) Fire-fighting system
AU2001232796A1 (en) Detergent tablet
AU2001234901A1 (en) Detergent tablet

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase